1) Pollack A, et al : Prostate Cancer Radiation Dose Response : Results of the M. D. Anderson Phase III Randomized Trial. Int J Radiat Oncol Biol Phys 53 : 1097-1105, 2002
2) Zietman A, et al : Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate : A Randomized Controlled Trial. JAMA 294 : 1233-1239, 2005
3) Machalsky JM, et al : Effect of Standard vs Dose-Escalated Radiation Therapy for Patients with Intermediate-Risk Prostate Cancer : The NRG Oncology RTOG 0126 Randomized Clinical Trial. JAMA Oncol 4 : e180039, 2018
4) Viani GA, et al : Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment : A Meta-Analysis of Randomized, Controlled Trials. Int J Radiat Oncol Biol Phys 74 : 1405-1418, 2009
5) Fowler JF, et al : What Hypofractionated Protocols Should Be Tested for Prostate Cancer? Int J Radiat Oncol Biol Phys 56 : 1093-1104, 2003
6) Pollack A, et al : Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate Cancer. J Clin Oncol 31 : 3860-3868, 2013
7) Kuban DA, et al : Preliminary Report of a Randomized Dose Escalation Trial for Prostate Cancer Using Hypofractionation. Int J Radiat Oncol Biol Phys 78 (Suppl) : s58-s59, 2010
8) Incrocci L, et al : Hypofractionated versus Conventionally Fractionated Radiotherapy for Patients with Localised Prostate Cancer (HYPRO) : Final Efficacy Results from a Randomised, Multicentre, Open-Label, Phase 3 Trial. Lancet Oncol 17 : 1061-1069, 2016
9) Hoffman KE, et al : Risk of Late Toxicity in Men Receiving Dose-Escalated Hypofractionated Intensity Modulated Prostate Radiation Therapy : Results from a Randomized Trial. Int J Radiat Oncol Biol Phys 88 : 1074-1084, 2014
10) Lee WR, et al : Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients with Low-Risk Prostate Cancer. J Clin Oncol 34 : 2325-2332, 2016
11) Dearnaley D, et al : Conventional versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy for Prostate Cancer : 5-Year Outcomes of the Randomised, Non-Inferiority, Phase 3 CHHiP Trial. Lancet Oncol 17 : 1047-1060, 2016
12) Catton CN, et al : Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer. J Clin Oncol 35 : 1884-1890, 2017
13) Nihei K, et al : A Japanese Multi-Institutional Phase II Study of Moderate Hypofractionated Intensity-Modulated Radiotherapy with Image-Guided Technique for Prostate Cancer. Int J Radiat Oncol Biol Phys 111 (Suppl) : E288, 2021